United States · FDA National Drug Code directory
Carbidopa-levodopa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-107_519a6595-11b5-ab1c-e063-6394a90a0223
- Product NDC
- 72888-107
- Form
- TABLET
- Composition / generic term
- carbidopa and levodopa
- Labeler
- Advagen Pharma Ltd.,
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220921
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 25 mg/1
- LEVODOPA — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (72888-107-00) · 72888-107-00
- 100 TABLET in 1 BOTTLE (72888-107-01) · 72888-107-01
- 500 TABLET in 1 BOTTLE (72888-107-05) · 72888-107-05
- 30 TABLET in 1 BOTTLE (72888-107-30) · 72888-107-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →